Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Tenofovir raises the risk of kidney dysfunction among people with HIV, but the adverse effect occurs mostly within the first two years.
Many people living with HIV experience multiple health complications as they age, which appears to be partly driven by rising obesity.
If you’re living with HIV, over 50 years of age and haven’t yet started antiretroviral (ARV) therapy, revised guidelines from the U.S...
Tenofovir is associated with an increased risk of kidney damage and disease that increases over time and doesn’t appear to be reversible.
People coinfected with both HIV and hepatitis B virus (HBV) who have more significant liver damage (fibrosis) are much more likely to develop...
An analysis of 17 studies, involving nearly 11,000 patients, found that while tenofovir (found in Viread, Truvada and Atripla) can negatively...
A new study has found that the overall rate of kidney dysfunction was only 3 percent in a group of HIV-positive military personnel, but severa...
Kidney damage caused by tenofovir (found in Viread, Truvada and Atripla) may not reverse itself after a year of discontinuing the drug, accord...
Continued use of two commonly used antiretrovirals (ARVs) is associated with an increased risk of kidney function deterioration.
Half of the deaths in people with HIV now are from causes other than AIDS
HIV-positive people undergoing a kidney transplant are just as likely to survive and thrive with their new organ as HIV-negative individuals r...
African Americans living with HIV and chronic kidney disease (CKD) progress far more rapidly to end-stage renal disease (ESRD)—requiring...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.